Nanoparticles (NPs) have emerged as an effective modality for the treatment of various
diseases including cancer, cardiovascular and inflammatory diseases. Various forms of NPs …

Stimuli-responsive cross-linked micelles (SCMs) represent an ideal nanocarrier system for
drug delivery against cancers. SCMs exhibit superior structural stability compared to their …

Abstract pH responsive cisplatin prodrug crosslinked polysaccharide-based nanoparticles
were developed from succinic acid decorated dextran (Dex-SA) for active loading and …

Traditional chemotherapy used today at clinics is mainly inherited from the thinking and
designs made four decades ago when the Cancer War was declared. The potency of those …

In the recent decades, polymers are widely used as biomaterials due to their favorable
properties such as good biocompatibility, easy design and preparation, a variety of …

Vaccine adjuvants are applied to amplify the recipient's specific immune responses against
pathogen infection or malignancy. A new generation of adjuvants is being developed to …

Efficient delivery of DNA‐toxin anticancer drugs into nucleus of targeted tumor cells while
simultaneously minimizing the side effects to normal tissue is a major challenge for cancer …

Nanotechnology has had a huge impact on the development of therapeutics over the last
couple of decades. To date, a large number of organic nanoparticles have been developed …

Peptide-based biomaterials have been extensively investigated for biomedical applications
due to their high structural and functional versatility. Particularly, peptides that can respond …

Ideal “smart” nanoparticles for drug delivery should enhance therapeutic efficacy without
introducing side effects. To achieve that, we developed a drug delivery system (HCN) based …